Infectious Disease
RSSArticles
-
APIC: Proposed changes to human research rule could have unintended consequences
The Association for Professionals in Infection Control and Epidemiology warns that proposed revisions to the Federal Policy for the Protection of Human Subjects – the “Common Rule” – may have unintended consequences if infection prevention research is not excluded from approval by IRBs.
-
HCV infections in Utah hospitals linked to drug diverter
Two Utah hospitals have notified thousands of patients that they may have been exposed to hepatitis C virus linked to an infected nurse with a history of drug diversion.
-
Ebola survivors suffer lingering symptoms
U.S. healthcare workers who survived Ebola after acquiring it from patients have suffered a wide variety of symptoms and maladies, with only one survivor considered symptom-free at five months after discharge, according to the Centers for Disease Control and Prevention.
-
CMS targets infection control in care transitions
The Centers for Medicare and Medicaid Services continues to expand its regulatory reach in infection control, recently announcing a pilot project to assess the infection risks during transitions of care between hospitals and nursing homes.
-
Think global, act local
Antibiotic resistance is an exploding global problem that individual nations must face to preserve the dwindling arsenal of infection-fighting drugs, according to a new report by the Center for Disease Dynamics, Economics & Policy in Washington, D.C.
-
Infections Are At Risk Of Becoming Unpreventable
A warning flag of the post-antibiotic era signals urgency for much needed action on drug stewardship.
-
Clinical Briefs
In this section: revisiting cancer screening recommendations; weighing the benefits of a COPD treatment; and expanding the safe prescribing of metformin.
-
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (Genvoya)
A complete regimen for the treatment of HIV-1 infections in adults and pediatric patients ≥ 12 years of age.
-
Fecal Microbiota Transplantation: Patients Need No Convincing
Fecal microbiota transplantation appears effective in approximately 55-90% of patients with relapsing and refractory Clostridium difficile infection, and will prove a blessing to those who have been in a miserable cycle of recurrent disease.
-
Optimal Beta-blocker Dose Post-MI
Investigators from the Outcome of Beta-blocker Therapy After Myocardial Infarction (OBTAIN) study hypothesized that the higher the dose of beta-blocker the lower the mortality.